Get the latest Science News and Discoveries

Phase 1 Study Supports Recommended Phase 3 Dose for Investigational EGFR x HER3 Antibody-Drug Conjugate in EGFR-Mutated Lung Cancer

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app